gastric-cancer

Documents about gastric-cancer

• Extensive intraoperative peritoneal lavage (EIPL) for gastric cancer with positive peritoneal lavage and/or stamp cytology: An exploratory phase II study#28673PLOS
• ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort#801877ClinicalTrials.gov
• FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors#148776ClinicalTrials.gov
• FLOT vs. FLOT/Herceptin/Pertuzumab for Perioperative Therapy of HER-2 Expressing Gastric or GEJ Cancer#865816ClinicalTrials.gov
• FAPI PET Imaging - An Exploratory Study#870195ClinicalTrials.gov
• Disitamab Vedotin, Fruquintinib and Tislelizumab in Second-line Treatment for HER2-positive MGC#160342ClinicalTrials.gov
• Study of Tislelizumab in Combination With SOX for the Treatment of Gastric Cancer With Liver Metastases#172328ClinicalTrials.gov
• A 15-layer multi-omics analysis of gastric cancer ecotypes provides therapeutic insights.#222937NCBI PubMed Central
• The Impact of DRG Payments on Nutritional Therapy Costs for Gastric Cancer Surgery Patients.#232568NCBI PubMed Central
• A multiomics Mendelian randomization study on PANoptosis-related genes and gastric cancer risk.#236296NCBI PubMed Central
• Collagen depletion by pirfenidone enhances antitumor effect of oncolytic adenovirus against peritoneal metastases of gastric cancer#292634OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Preoperative HFRT Verses PULSAR for Locally Advanced GEJ or Proximal Gastric Adenocarcinoma#303751ClinicalTrials.gov
• Analysis of risk factors for peritoneal metastasis in patients with advanced gastric cancer.#322941NCBI PubMed Central
• Artificial intelligence for biomarker prediction in gastric cancer: from histopathology to multimodal integration.#330812NCBI PubMed Central
• Precision oncology in gastric cancer: navigating molecular subtypes, therapeutic targets, and future horizons.#342485NCBI PubMed Central
• Early detection of gastric cancer with the assistance of cell-free DNA fragmentomics.#375460NCBI PubMed Central
• The interplay of the microbiome, host genetics, and epigenetic modifications in gastric cancer.#434010NCBI PubMed Central
• The role of gastric cancer patient-derived organoids in precision medicine: Clinicians' perspective.#458711NCBI PubMed Central
• Exosome-orchestrated network in gastric cancer: mechanisms, immune regulation, biomarkers and therapeutic vehicles.#476888NCBI PubMed Central
• DPP3-mediated Destabilization of SLC3A2 Promotes Ferroptosis and Restores Chemosensitivity in Gastric Cancer#676353Europe PMC
• Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy#857033ClinicalTrials.gov
• Trastuzumab Deruxtecan(T-DXd) and Afatinib Combination in HER2-low Advanced Gastric Cancer#865091ClinicalTrials.gov
• Pembrolizumab + Capecitabine／Oxaliplatin (CapeOx) -HER2 Nagative and Pembrolizumab + Trastuzumab + Cisplatin/Capecitabine HER2 Positive#871129ClinicalTrials.gov
• Efficacy and Safety of Fruquintinib With Sintilimab as First-line Therapy in Gastric Cancer#893105ClinicalTrials.gov
• A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors#804570ClinicalTrials.gov
• TKM 080301 for Primary or Secondary Liver Cancer#914453ClinicalTrials.gov
• Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors#833985ClinicalTrials.gov
• Neo-Sequence 2：NCT Plus Anti-angiogenesis Therapy and Immunotherapy for LADGC#834480ClinicalTrials.gov
• A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)#903968ClinicalTrials.gov
• The Efficacy and Safety of Iparomlimab/Tuvonralimab (Anti PD-1/CTLA-4) Combined With Albumin-bound Paclitaxel in Second-line Treatment of Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma#127566ClinicalTrials.gov
• Full-time RDI for ESD: Impact on Major Adverse Events and Procedure Time#859190ClinicalTrials.gov
• Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1#843086ClinicalTrials.gov
• A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer#834037ClinicalTrials.gov
• A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors#854375ClinicalTrials.gov
• A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors#830273ClinicalTrials.gov
• Efficacy and Safety of Hou Gu Mi Xi in Patients With Spleen Qi Deficiency and Radical Gastrectomy for Gastric Cancer#831257ClinicalTrials.gov
• Trial on the Evaluation of Pylorus-ring in Pancreaticoduodenectomy#837847ClinicalTrials.gov
• Phase II Study of Neoadjuvant Immune Checkpoint Inhibitor in Patients With Resectable Gastrointestinal Cancers#891741ClinicalTrials.gov
• Roux-en-Y vs. Roux-en-Y+ Pouch for D2 Total Gastrectomy#873529ClinicalTrials.gov
• Aggregated hospital discharge rates and age-standardization pipeline for gastric cancer in Chile, 2018-2022#122287DataCite
• Aggregated hospital discharge rates and age-standardization pipeline for gastric cancer in Chile, 2018-2022#122288DataCite
• Prognostic significance and model evaluation of the modified advanced lung cancer inflammation index in locally advanced resectable gastric cancer patients with neoadjuvant chemotherapy.#295220NCBI PubMed Central
• Oxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagus Cancer#886579ClinicalTrials.gov
• A Phase 2 Clinical Study of ABSK061 and ABSK043#909127ClinicalTrials.gov
• A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)#994476ClinicalTrials.gov
• Correlation of immune-inflammatory and tumor markers with lymph node metastasis in gastric cancer.#30575NCBI PubMed Central
• Molecular and structural reprogramming of gastric cancer revealed by systems-level transcriptomic analysis.#218855NCBI PubMed Central
• Developing and Interpreting a Machine Learning Model for Identifying Liver Metastasis in Gastric Cancer.#218894NCBI PubMed Central
• Data requirements of an informative, directive, and preventive mobile health application for gastric cancer.#244292NCBI PubMed Central
• A machine learning‑enhanced serum metabolomics model for non‑invasive detection of gastric cancer.#258122NCBI PubMed Central